Investing Ideas
/
Belgian Pharmaceuticals & Biotech Price disconnect

Belgian Pharmaceuticals & Biotech Price disconnect

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Stocks which the market has priced substantially different to their cash flows, which could imply risk.

1 companies

UCB

Market Cap: €42.7b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

UCB

€224.10

3.1%

12.2%